CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit ...

Vertex Pharmaceuticals has hit a snag in its efforts to follow up non-opioid pain reliever Journavx (suzetrigine). | Vertex ...

I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.

Google suggested that vacation pictures, children’s drawings, and real life circumstances could be used to create AI ...